|
GS185131: GO:0044699 single-organism process
|
|
GS187754: GO:0019229 regulation of vasoconstriction
|
|
GS204615: GO:0019229 regulation of vasoconstriction
|
|
GS135990: Hfe modifier 3 (Hfem3, Published QTL Chr 11)
|
|
GS192507: GO:0006812 cation transport
|
|
GS186110: GO:0006939 smooth muscle contraction
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS135864: femur length in high growth mice 4 (Feml4, Published QTL Chr 11)
|
|
GS206767: GO:0014829 vascular smooth muscle contraction
|
|
GS136647: serum IGFBP-5 level QTL 6 (Si5lq6, Published QTL Chr 11)
|
|
GS201949: GO:0044699 single-organism process
|
|
GS166951: MP:0001156 abnormal spermatogenesis
|
|
GS210096: GO:0032940 secretion by cell
|
|
GS135637: cytokine induced activation 1 (Cinda1, Published QTL Chr 11)
|
|
GS180039: GO:0032504 multicellular organism reproduction
|
|
GS166812: MP:0002209 decreased germ cell number
|
|
GS190397: GO:0032879 regulation of localization
|
|
GS205510: GO:0001883 purine nucleoside binding
|
|
GS188641: GO:0071944 cell periphery
|
|
GS183480: GO:0014070 response to organic cyclic compound
|
|
GS196233: GO:0001820 serotonin secretion
|
|
GS189855: GO:0043168 anion binding
|
|
GS136853: Theiler's murine encephalomyelitis virus induced demyelinating disease susceptibility 5 (Tmevd5, Published QTL Chr 11)
|
|
GS181117: GO:0035586 purinergic receptor activity
|
|
GS178461: GO:0009987 cellular process
|
|
GS193941: GO:0035381 ATP-gated ion channel activity
|
|
GS188698: GO:0003012 muscle system process
|
|
GS196560: GO:0019867 outer membrane
|
|
GS179402: GO:0005216 ion channel activity
|
|
GS202969: GO:0007320 insemination
|
|
GS203505: GO:0030148 sphingolipid biosynthetic process
|
|
GS186065: GO:0050878 regulation of body fluid levels
|
|
GS192041: GO:0043169 cation binding
|
|
GS210507: GO:0006950 response to stress
|
|
GS177218: GO:0035381 ATP-gated ion channel activity
|
|
GS136605: spinal bone mineral density 4 (Sbmd4, Published QTL Chr 11)
|
|
GS184984: GO:0032553 ribonucleotide binding
|
|
GS188075: GO:0003056 regulation of vascular smooth muscle contraction
|
|
GS187033: GO:0006887 exocytosis
|
|
GS136658: skeletal muscle weight 17 (Skmw17, Published QTL Chr 11)
|
|
GS179428: GO:0022414 reproductive process
|
|
GS198498: GO:0050801 ion homeostasis
|
|
GS191792: GO:0070271 protein complex biogenesis
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS183197: GO:0015276 ligand-gated ion channel activity
|
|
GS183645: GO:0017076 purine nucleotide binding
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS196934: GO:0065008 regulation of biological quality
|
|
GS204270: GO:0005230 extracellular ligand-gated ion channel activity
|
|
GS184217: GO:0071705 nitrogen compound transport
|
|
GS189218: GO:0007618 mating
|
|
GS191083: GO:0000003 reproduction
|
|
GS193151: GO:0032940 secretion by cell
|
|
GS167063: MP:0001929 abnormal gametogenesis
|
|
GS129171: pregnancy QTL 1 (Pregq1 Published QTL Chr 11)
|
|
GS190829: GO:0052547 regulation of peptidase activity
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS203485: GO:0001614 purinergic nucleotide receptor activity
|
|
GS190371: GO:0090066 regulation of anatomical structure size
|
|
GS199873: GO:0010950 positive regulation of endopeptidase activity
|
|
GS204349: GO:0002351 serotonin production involved in inflammatory response
|
|
GS136432: pulmonary adenoma susceptibility 5 (Pas5, Published QTL Chr 11)
|
|
GS166753: MP:0001935 decreased litter size
|
|
GS136798: total body bone mineral density 5 (Tbbmd5, Published QTL Chr 11)
|
|
GS186442: GO:0071822 protein complex subunit organization
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS197443: GO:0032549 ribonucleoside binding
|
|
GS136208: liver weight QTL 9 (Lwq9, Published QTL Chr 11)
|
|
GS177992: GO:0030168 platelet activation
|
|
GS84252: alcohol preference locus (Published QTL, Chr 11)
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS191189: GO:0033198 response to ATP
|
|
GS196883: GO:0097060 synaptic membrane
|
|
GS181423: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS182313: GO:0044085 cellular component biogenesis
|
|
GS196920: GO:0048878 chemical homeostasis
|
|
GS187409: GO:0005231 excitatory extracellular ligand-gated ion channel activity
|
|
GS192279: GO:0007166 cell surface receptor signaling pathway
|
|
GS205165: GO:0010243 response to organic nitrogen
|
|
GS135496: brain weight QTL 1 (Brwq1, Published QTL Chr 11)
|
|
GS178334: GO:0007267 cell-cell signaling
|
|
GS169835: MP:0005389 reproductive system phenotype
|
|
GS201022: GO:0071705 nitrogen compound transport
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS201737: GO:0007596 blood coagulation
|
|
GS126886: Malathion interacting genes (MeSH:D008294) in CTD
|
|
GS196343: GO:0036094 small molecule binding
|
|
GS196857: GO:0034220 ion transmembrane transport
|
|
GS191106: GO:0044464 cell part
|
|
GS179517: GO:0012501 programmed cell death
|
|
GS177570: GO:0016043 cellular component organization
|
|
GS135528: castaneus 10 week body weight 3 (C10bw3, Published QTL Chr 11)
|
|
GS194737: GO:0030168 platelet activation
|
|
GS178359: GO:0071840 cellular component organization or biogenesis
|
|
GS192669: GO:0055082 cellular chemical homeostasis
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS136767: streptozotocin induced diabetes susceptibility (Stzid, Published QTL Chr 11)
|
|
GS191176: GO:0030312 external encapsulating structure
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS206066: GO:0010952 positive regulation of peptidase activity
|
|
GS177440: GO:0006915 apoptotic process
|
|
GS192508: GO:0006811 ion transport
|
|
GS193662: GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS181116: GO:0035587 purinergic receptor signaling pathway
|
|
GS205814: GO:0022834 ligand-gated channel activity
|
|
GS202605: GO:0006643 membrane lipid metabolic process
|
|
GS183543: GO:0051179 localization
|
|
GS177862: GO:0001775 cell activation
|
|
GS204614: GO:0019228 regulation of action potential in neuron
|
|
GS126899: Methyl Parathion interacting genes (MeSH:D008743) in CTD
|
|
GS136696: systematic lupus erythematosus susceptibility 13 (Sle13, Published QTL Chr 11)
|
|
GS188704: GO:0003018 vascular process in circulatory system
|
|
GS136294: modifier of Trp53 1 (Motp1, Published QTL Chr 11)
|
|
GS136481: plasmacytoma susceptibility 3 (Pcyts3, Published QTL Chr 11)
|
|
GS163843: MP:0000231 hypertension
|
|
GS178803: GO:0051336 regulation of hydrolase activity
|
|
GS205500: GO:0071944 cell periphery
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS136581: red blood cell QTL 3 (Rbcq3, Published QTL Chr 11)
|
|
GS189819: GO:0044703 multi-organism reproductive process
|
|
GS209108: GO:0000166 nucleotide binding
|
|
GS202329: GO:0007620 copulation
|
|
GS203688: GO:0008270 zinc ion binding
|
|
GS184509: GO:0045211 postsynaptic membrane
|
|
GS186109: GO:0006937 regulation of muscle contraction
|
|
GS208514: GO:0031240 external side of cell outer membrane
|
|
GS178155: GO:0008219 cell death
|
|
GS203494: GO:0051704 multi-organism process
|
|
GS189374: GO:0042981 regulation of apoptotic process
|
|
GS136901: ventral midbrain iron content 6 (Vmbic6, Published QTL Chr 11)
|
|
GS191408: GO:0051924 regulation of calcium ion transport
|
|
GS196790: GO:0046903 secretion
|
|
GS188652: GO:0001882 nucleoside binding
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS136877: tooth shape 10 (Tshp10, Published QTL Chr 11)
|
|
GS204106: GO:0060089 molecular transducer activity
|
|
GS193632: GO:0051649 establishment of localization in cell
|
|
GS205653: GO:0070838 divalent metal ion transport
|
|
GS208978: GO:0043169 cation binding
|
|
GS196169: GO:0005216 ion channel activity
|
|
GS179465: GO:0001820 serotonin secretion
|
|
GS201799: GO:0032550 purine ribonucleoside binding
|
|
GS201800: GO:0032553 ribonucleotide binding
|
|
GS189883: GO:0014829 vascular smooth muscle contraction
|
|
GS196667: GO:0008610 lipid biosynthetic process
|
|
GS189748: GO:0050790 regulation of catalytic activity
|
|
GS135973: wound healing/regeneration 10 (Heal10, Published QTL Chr 11)
|
|
GS194455: GO:0051239 regulation of multicellular organismal process
|
|
GS206696: GO:0044702 single organism reproductive process
|
|
GS190817: GO:0048609 multicellular organismal reproductive process
|
|
GS192671: GO:0055085 transmembrane transport
|
|
GS189165: GO:0072511 divalent inorganic cation transport
|
|
GS199790: GO:0046683 response to organophosphorus
|
|
GS195226: GO:0015075 ion transmembrane transporter activity
|
|
GS180852: GO:0006954 inflammatory response
|
|
GS188651: GO:0001883 purine nucleoside binding
|
|
GS206085: GO:0007618 mating
|
|
GS208088: GO:0030312 external encapsulating structure
|
|
GS206237: GO:0042981 regulation of apoptotic process
|
|
GS189106: GO:0008015 blood circulation
|
|
GS202943: GO:0006939 smooth muscle contraction
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS204933: GO:0003056 regulation of vascular smooth muscle contraction
|
|
GS136325: non-insulin-dependent diabetes mellitus 1 in NSY (Nidd1n, Published QTL Chr 11)
|
|
GS189484: GO:0023052 signaling
|
|
GS201696: GO:0010941 regulation of cell death
|
|
GS179401: GO:0005215 transporter activity
|
|
GS188792: GO:0070838 divalent metal ion transport
|
|
GS207720: GO:0048609 multicellular organismal reproductive process
|
|
GS135793: ethanol induced low dose activation 1 (Elda1, Published QTL Chr 11)
|
|
GS169220: MP:0005159 azoospermia
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS195222: GO:2001056 positive regulation of cysteine-type endopeptidase activity
|
|
GS178913: GO:0042221 response to chemical stimulus
|
|
GS198782: GO:0044459 plasma membrane part
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS186655: GO:0035249 synaptic transmission, glutamatergic
|
|
GS124516: Parathion interacting genes (MeSH:D010278) in CTD
|
|
GS136952: weight gain in high growth mice 7 (Wg7, Published QTL Chr 11)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS205812: GO:0022836 gated channel activity
|
|
GS135812: estradiol regulated response QTL 3 (Estq3, Published QTL Chr 11)
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS198853: GO:0006672 ceramide metabolic process
|
|
GS179898: GO:0008610 lipid biosynthetic process
|
|
GS208021: GO:0051345 positive regulation of hydrolase activity
|
|
GS209454: GO:0006816 calcium ion transport
|
|
GS200202: GO:0015844 monoamine transport
|
|
GS183274: GO:0035590 purinergic nucleotide receptor signaling pathway
|
|
GS194078: GO:0042391 regulation of membrane potential
|
|
GS180532: GO:0050880 regulation of blood vessel size
|
|
GS210586: GO:0051641 cellular localization
|
|
GS185254: GO:0051259 protein oligomerization
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS189860: GO:0043167 ion binding
|
|
GS208187: GO:0010033 response to organic substance
|
|
GS122805: aluminum sulfate interacting genes (MeSH:C041524) in CTD
|
|
GS209842: GO:0042310 vasoconstriction
|
|
GS180142: GO:0048878 chemical homeostasis
|
|
GS204150: GO:0009611 response to wounding
|
|
GS184448: GO:0044425 membrane part
|
|
GS204054: GO:0044057 regulation of system process
|
|
GS190830: GO:0052548 regulation of endopeptidase activity
|
|
GS194556: GO:0031975 envelope
|
|
GS186636: GO:0001614 purinergic nucleotide receptor activity
|
|
GS196927: GO:0065003 macromolecular complex assembly
|
|
GS183476: GO:0014074 response to purine-containing compound
|
|
GS178442: GO:0015837 amine transport
|
|
GS180672: GO:0044456 synapse part
|
|
GS198213: GO:0022890 inorganic cation transmembrane transporter activity
|
|
GS187747: GO:0019226 transmission of nerve impulse
|
|
GS194307: GO:0016043 cellular component organization
|
|
GS199199: GO:0031226 intrinsic to plasma membrane
|
|
GS135966: HDL QTL 37 (Hdlq37, Published QTL Chr 11)
|
|
GS191175: GO:0030313 cell envelope
|
|
GS200341: GO:0051179 localization
|
|
GS206742: GO:0043167 ion binding
|
|
GS183767: GO:0019725 cellular homeostasis
|
|
GS197957: GO:0006940 regulation of smooth muscle contraction
|
|
GS177814: GO:0031975 envelope
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS180021: GO:0046903 secretion
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS195082: GO:0007268 synaptic transmission
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS164310: MP:0004806 absent germ cells
|
|
GS208041: GO:0015085 calcium ion transmembrane transporter activity
|
|
GS136119: body length 6 (Lgth6, Published QTL Chr 11)
|
|
GS165208: MP:0002842 increased systemic arterial blood pressure
|
|
GS196342: GO:0097202 activation of cysteine-type endopeptidase activity
|
|
GS205816: GO:0022839 ion gated channel activity
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS188699: GO:0003013 circulatory system process
|
|
GS136528: prion disease incubation time 3 (Prdt3, Published QTL Chr 11)
|
|
GS181473: GO:0005488 binding
|
|
GS136388: autoimmune orchitis resistance 3 (Orch3, Published QTL Chr 11)
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS206720: GO:0035150 regulation of tube size
|
|
GS200731: GO:0006837 serotonin transport
|
|
GS180644: GO:0032549 ribonucleoside binding
|
|
GS207616: GO:0016020 membrane
|
|
GS182559: GO:0005261 cation channel activity
|
|
GS186645: GO:0051704 multi-organism process
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS179796: GO:0019867 outer membrane
|
|
GS185880: GO:0035637 multicellular organismal signaling
|
|
GS186994: GO:0051291 protein heterooligomerization
|
|
GS183310: GO:0009279 cell outer membrane
|
|
GS179304: GO:0009636 response to toxin
|
|
GS203896: GO:0006887 exocytosis
|
|
GS129115: collagen induced arthritis 40 (Cia40 Published QTL Chr 11)
|
|
GS207732: GO:0052547 regulation of peptidase activity
|
|
GS177094: GO:0006629 lipid metabolic process
|
|
GS135519: body weight at necropsy 3 (Bwtn3, Published QTL Chr 11)
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS178333: GO:0007268 synaptic transmission
|
|
GS189479: GO:0046513 ceramide biosynthetic process
|
|
GS179132: GO:0044255 cellular lipid metabolic process
|
|
GS192680: GO:0038023 signaling receptor activity
|
|
GS200271: GO:0014074 response to purine-containing compound
|
|
GS177371: GO:0050817 coagulation
|
|
GS210023: GO:0070588 calcium ion transmembrane transport
|
|
GS167074: MP:0001925 male infertility
|
|
GS26227: Neocortex Gene expression correlates of Thermal Nociception Hot Plate Avg of 2Trials in Females BXD
|
|
GS184884: GO:0010941 regulation of cell death
|
|
GS163427: MP:0009205 abnormal internal male genitalia morphology
|
|
GS163916: MP:0009198 abnormal male genitalia morphology
|
|
GS186067: GO:0050877 neurological system process
|
|
GS209199: GO:0007165 signal transduction
|
|
GS206541: GO:2000116 regulation of cysteine-type endopeptidase activity
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS34277: Hippocampus Gene expression correlates of Activity in 30 second interval post 2nd tone shock pairing in Females BXD
|
|
GS193018: GO:0003008 system process
|
|
GS197325: GO:0050880 regulation of blood vessel size
|
|
GS199781: GO:0043067 regulation of programmed cell death
|
|
GS188813: GO:0045202 synapse
|
|
GS185505: GO:0007620 copulation
|
|
GS209957: GO:0003001 generation of a signal involved in cell-cell signaling
|
|
GS135868: fat induced adiposity 1 (Fina1, Published QTL Chr 11)
|
|
GS206737: GO:0043168 anion binding
|
|
GS136477: periosteal circumference 2 (Pcir2, Published QTL Chr 11)
|
|
GS182858: GO:0004931 extracellular ATP-gated cation channel activity
|
|
GS178812: GO:0015267 channel activity
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS200106: GO:0009279 cell outer membrane
|
|
GS187881: GO:0004888 transmembrane signaling receptor activity
|
|
GS199986: GO:0009719 response to endogenous stimulus
|
|
GS205674: GO:0045202 synapse
|
|
GS202942: GO:0006937 regulation of muscle contraction
|
|
GS189525: GO:0051260 protein homooligomerization
|
|
GS166712: MP:0002161 abnormal fertility/fecundity
|
|
GS192896: GO:0042310 vasoconstriction
|
|
GS183188: GO:0009719 response to endogenous stimulus
|
|
GS205558: GO:0003013 circulatory system process
|
|
GS196074: GO:0009636 response to toxin
|
|
GS191548: GO:0016502 nucleotide receptor activity
|
|
GS179671: GO:0030001 metal ion transport
|
|
GS135686: C. trachomatis resistance QTL 3 (Ctrq3, Published QTL Chr 11)
|
|
GS208730: GO:0070271 protein complex biogenesis
|
|
GS208478: GO:0016502 nucleotide receptor activity
|
|
GS188954: GO:0022838 substrate-specific channel activity
|
|
GS193015: GO:0003001 generation of a signal involved in cell-cell signaling
|
|
GS135823: ethanol conditioned taste aversion 9 (Etohcta9, Published QTL Chr 11)
|
|
GS208012: GO:0044464 cell part
|
|
GS183933: GO:0006837 serotonin transport
|
|
GS201252: GO:0044425 membrane part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS201669: GO:0072509 divalent inorganic cation transmembrane transporter activity
|
|
GS135766: experimental allergic encephalomyelitis susceptibility 7 (Eae7, Published QTL Chr 11)
|
|
GS136444: peak bone mineral density 4 (Pbmd4, Published QTL Chr 11)
|
|
GS177334: GO:0016192 vesicle-mediated transport
|
|
GS202633: GO:0023061 signal release
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS185796: GO:0023061 signal release
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS182139: GO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS192511: GO:0006816 calcium ion transport
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS207266: GO:0090066 regulation of anatomical structure size
|
|
GS163635: MP:0001933 abnormal litter size
|
|
GS168520: MP:0004901 decreased male germ cell number
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS180083: GO:0034220 ion transmembrane transport
|
|
GS209451: GO:0006811 ion transport
|
|
GS181708: GO:0050801 ion homeostasis
|
|
GS182991: GO:0046683 response to organophosphorus
|
|
GS206350: GO:0046513 ceramide biosynthetic process
|
|
GS193563: GO:0006950 response to stress
|
|
GS206059: GO:0010959 regulation of metal ion transport
|
|
GS194101: GO:0050817 coagulation
|
|
GS206695: GO:0044703 multi-organism reproductive process
|
|
GS207015: GO:0042592 homeostatic process
|
|
GS34262: Hippocampus Gene expression correlates of Suppression of activity in altered context in Males BXD
|
|
GS179580: GO:0036094 small molecule binding
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS201792: GO:0032559 adenyl ribonucleotide binding
|
|
GS201313: GO:0045211 postsynaptic membrane
|
|
GS184923: GO:0007596 blood coagulation
|
|
GS192789: GO:0008324 cation transmembrane transporter activity
|
|
GS190899: GO:0043005 neuron projection
|
|
GS168295: MP:0003698 abnormal male reproductive system physiology
|
|
GS184220: GO:0071702 organic substance transport
|
|
GS196432: GO:0030001 metal ion transport
|
|
GS186314: GO:0002576 platelet degranulation
|
|
GS189194: GO:0010959 regulation of metal ion transport
|
|
GS199995: GO:0015276 ligand-gated ion channel activity
|
|
GS166711: MP:0002160 abnormal reproductive system morphology
|
|
GS210609: GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS188949: GO:0022836 gated channel activity
|
|
GS136543: periosteal circumference 2 (Pstc2, Published QTL Chr 11)
|
|
GS195733: GO:0022607 cellular component assembly
|
|
GS203755: GO:0016265 death
|
|
GS136864: T cell receptor induced activation 1 (Tria1, Published QTL Chr 11)
|
|
GS183409: GO:0015844 monoamine transport
|
|
GS198933: GO:0006919 activation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS167367: MP:0002208 abnormal germ cell morphology
|
|
GS193661: GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS181425: GO:0022892 substrate-specific transporter activity
|
|
GS182834: GO:0005623 cell
|
|
GS136434: pulmonary adenoma susceptibility 5b (Pas5b, Published QTL Chr 11)
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS202075: GO:0051259 protein oligomerization
|
|
GS135702: dopamine uptake transporter binding 4 (Dautb4, Published QTL Chr 11)
|
|
GS205511: GO:0001882 nucleoside binding
|
|
GS199591: GO:0042060 wound healing
|
|
GS194404: GO:0006665 sphingolipid metabolic process
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS184927: GO:0001508 regulation of action potential
|
|
GS135275: "alcohol preference locus 2, female specific" (Alcp2, Published QTL Chr 11)
|
|
GS205817: GO:0022838 substrate-specific channel activity
|
|
GS135593: P. chabaudi malaria resistance QTL 8 (Char8, Published QTL Chr 11)
|
|
GS167075: MP:0001924 infertility
|
|
GS189820: GO:0044702 single organism reproductive process
|
|
GS196943: GO:0008152 metabolic process
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS136907: vertebral morphology and mechanical traits 12 (Vmmt12, Published QTL Chr 11)
|
|
GS201733: GO:0007599 hemostasis
|
|
GS169161: MP:0006362 abnormal male germ cell morphology
|
|
GS187753: GO:0019228 regulation of action potential in neuron
|
|
GS196941: GO:0008150 biological_process
|
|
GS198212: GO:0022891 substrate-specific transmembrane transporter activity
|
|
GS205563: GO:0003018 vascular process in circulatory system
|
|
GS199634: GO:0005623 cell
|
|
GS203289: GO:0071822 protein complex subunit organization
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS136161: leishmaniasis resistance 15 (Lmr15, Published QTL Chr 11)
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS209735: GO:0008324 cation transmembrane transporter activity
|
|
GS201289: GO:0008144 drug binding
|
|
GS203161: GO:0002576 platelet degranulation
|
|
GS205522: GO:0043269 regulation of ion transport
|
|
GS136337: nicotine induced locomotor activity 2 (Nilac2, Published QTL Chr 11)
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS185023: GO:0044462 external encapsulating structure part
|
|
GS206031: GO:0072511 divalent inorganic cation transport
|
|
GS196282: GO:0012501 programmed cell death
|
|
GS181878: GO:0090257 regulation of muscle system process
|
|
GS187485: GO:0002351 serotonin production involved in inflammatory response
|
|
GS188663: GO:0043269 regulation of ion transport
|
|
GS177347: GO:0042391 regulation of membrane potential
|
|
GS179828: GO:0006461 protein complex assembly
|
|
GS136708: semilethal sex-restricted (Slthsr, Published QTL Chr 11)
|
|
GS196933: GO:0065009 regulation of molecular function
|
|
GS203649: GO:0030554 adenyl nucleotide binding
|
|
GS184506: GO:0006873 cellular ion homeostasis
|
|
GS183091: GO:0043270 positive regulation of ion transport
|
|
GS187247: GO:0060089 molecular transducer activity
|
|
GS136560: QTL for body weight independent of sex 3 (Qbis3, Published QTL Chr 11)
|
|
GS190027: GO:0006952 defense response
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS136086: kidney weight QTL 15 (Kwq15, Published QTL Chr 11)
|
|
GS204271: GO:0005231 excitatory extracellular ligand-gated ion channel activity
|
|
GS181168: GO:0006940 regulation of smooth muscle contraction
|
|
GS209613: GO:0055085 transmembrane transport
|
|
GS166636: MP:0001124 abnormal gametes
|
|
GS199267: GO:0043234 protein complex
|
|
GS129152: immunity to S. typhimurium 2b (Ity2b Published QTL Chr 11)
|
|
GS199357: GO:0005261 cation channel activity
|
|
GS191115: GO:0051345 positive regulation of hydrolase activity
|
|
GS186881: GO:0002532 production of molecular mediator involved in inflammatory response
|
|
GS187163: GO:0044706 multi-multicellular organism process
|
|
GS178470: GO:2001056 positive regulation of cysteine-type endopeptidase activity
|
|
GS197463: GO:0002554 serotonin secretion by platelet
|
|
GS136611: colon tumor susceptibility 15 (Scc15, Published QTL Chr 11)
|
|
GS195569: GO:0015267 channel activity
|
|
GS136048: insulin dependent diabetes susceptibility 4 (Idd4, Published QTL Chr 11)
|
|
GS206620: GO:0050790 regulation of catalytic activity
|
|
GS187771: GO:1901566 organonitrogen compound biosynthetic process
|
|
GS184485: GO:0008144 drug binding
|
|
GS203738: GO:0002532 production of molecular mediator involved in inflammatory response
|
|
GS184976: GO:0032559 adenyl ribonucleotide binding
|
|
GS135430: bone mineral density 11 (Bmd11, Published QTL Chr 11)
|
|
GS136502: proteoglycan induced arthritis 7 (Pgia7, Published QTL Chr 11)
|
|
GS135919: graft-versus host disease 4 (Gvhd4, Published QTL Chr 11)
|
|
GS186899: GO:0016265 death
|
|
GS202799: GO:0051049 regulation of transport
|
|
GS209452: GO:0006810 transport
|
|
GS203503: GO:0035249 synaptic transmission, glutamatergic
|
|
GS204608: GO:0019226 transmission of nerve impulse
|
|
GS184065: GO:0043085 positive regulation of catalytic activity
|
|
GS135507: body weight QTL 4 (Bw4, Published QTL Chr 11)
|
|
GS179579: GO:0097202 activation of cysteine-type endopeptidase activity
|
|
GS202941: GO:0006936 muscle contraction
|
|
GS187876: GO:0045121 membrane raft
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS190178: GO:0051050 positive regulation of transport
|
|
GS136566: retinoic acid induced forelimb autopod reduction (Rafar, Published QTL Chr 11)
|
|
GS194244: GO:0046467 membrane lipid biosynthetic process
|
|
GS195559: GO:0051336 regulation of hydrolase activity
|
|
GS209291: GO:0046914 transition metal ion binding
|
|
GS196811: GO:0032504 multicellular organism reproduction
|
|
GS165821: MP:0001117 absent gametes
|
|
GS166543: MP:0002769 abnormal vas deferens morphology
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS179211: GO:0007154 cell communication
|
|
GS185920: GO:0004872 receptor activity
|
|
GS192265: GO:0007165 signal transduction
|
|
GS210608: GO:0043281 regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
|
GS180152: GO:0065007 biological regulation
|
|
GS185881: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS136219: mandible length 11 (Manln11, Published QTL Chr 11)
|
|
GS136302: modifier of Salmonella typhimurium susceptibility 3 (Msts3, Published QTL Chr 11)
|
|
GS189780: GO:0043933 macromolecular complex subunit organization
|
|
GS202760: GO:0004871 signal transducer activity
|
|
GS204024: GO:0044706 multi-multicellular organism process
|
|
GS135366: B.burgdorferi-associated arthritis 4 (Bbaa4, Published QTL Chr 11)
|
|
GS190678: GO:0007270 neuron-neuron synaptic transmission
|
|
GS192354: GO:0046914 transition metal ion binding
|
|
GS202899: GO:0050877 neurological system process
|
|
GS186078: GO:0022803 passive transmembrane transporter activity
|
|
GS187293: GO:0009611 response to wounding
|
|
GS202716: GO:0035639 purine ribonucleoside triphosphate binding
|
|
GS202759: GO:0004872 receptor activity
|
|
GS135353: Alzheimer's disease modifier 5 (Azdm5, Published QTL Chr 11)
|
|
GS128596: Change in rotarod latency over training trials Chr#11
|
|
GS129196: Tmc1 modifier 2 (Tmc1m2 Published QTL Chr 11)
|
|
GS84253: alcohol preference locus (Published QTL, Chr 11)
|
|
GS186633: GO:0044093 positive regulation of molecular function
|
|
GS196593: GO:0006461 protein complex assembly
|
|
GS194172: GO:0006915 apoptotic process
|
|
GS200446: GO:0017076 purine nucleotide binding
|
|
GS194900: GO:0008217 regulation of blood pressure
|
|
GS183075: GO:0010950 positive regulation of endopeptidase activity
|
|
GS209622: GO:0038023 signaling receptor activity
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS184983: GO:0032550 purine ribonucleoside binding
|
|
GS197644: GO:0006954 inflammatory response
|
|
GS210579: GO:0051649 establishment of localization in cell
|
|
GS197471: GO:0044456 synapse part
|
|
GS209960: GO:0003008 system process
|
|
GS136651: skeletal size (tail length) 5 (Skl5, Published QTL Chr 11)
|
|
GS178151: GO:0008217 regulation of blood pressure
|
|
GS188953: GO:0022839 ion gated channel activity
|
|
GS192174: GO:0000166 nucleotide binding
|
|
GS207991: GO:0000003 reproduction
|
|
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
|
|
GS186836: GO:0008270 zinc ion binding
|
|
GS136439: peak bone density 1 (Pbd1, Published QTL Chr 11)
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS188951: GO:0022834 ligand-gated channel activity
|
|
GS191580: GO:0031240 external side of cell outer membrane
|
|
GS194605: GO:0001775 cell activation
|
|
GS207071: GO:0051050 positive regulation of transport
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS191268: GO:0010033 response to organic substance
|
|
GS208332: GO:0051924 regulation of calcium ion transport
|
|
GS196196: GO:0022414 reproductive process
|
|
GS202908: GO:0022803 passive transmembrane transporter activity
|
|
GS136398: organ weight 7 (Org7, Published QTL Chr 11)
|
|
GS167267: MP:0001145 abnormal male reproductive system morphology
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS180149: GO:0065003 macromolecular complex assembly
|
|
GS135295: acute lung injury QTL 1 (Aliq1, Published QTL Chr 11)
|
|
GS177717: GO:0051239 regulation of multicellular organismal process
|
|
GS197908: GO:0035586 purinergic receptor activity
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS208103: GO:0033198 response to ATP
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS182061: GO:0006672 ceramide metabolic process
|
|
GS180166: GO:0008152 metabolic process
|
|
GS189548: GO:0002442 serotonin secretion involved in inflammatory response
|
|
GS180108: GO:0097060 synaptic membrane
|
|
GS136741: spermatocyte heat stress resistance 2 (Sphsr2, Published QTL Chr 11)
|
|
GS178474: GO:0015075 ion transmembrane transporter activity
|
|
GS200565: GO:0019725 cellular homeostasis
|
|
GS203886: GO:1901265 nucleoside phosphate binding
|
|
GS197610: GO:0022857 transmembrane transporter activity
|
|
GS198670: GO:0090257 regulation of muscle system process
|
|
GS204631: GO:1901566 organonitrogen compound biosynthetic process
|
|
GS199657: GO:0004931 extracellular ATP-gated cation channel activity
|
|
GS187408: GO:0005230 extracellular ligand-gated ion channel activity
|
|
GS204740: GO:0004888 transmembrane signaling receptor activity
|
|
GS84254: nicotine sensitivity (Published QTL,Chr 11)
|
|
GS136517: platelet count 2 (Pltct2, Published QTL Chr 11)
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS199891: GO:0043270 positive regulation of ion transport
|
|
GS136753: susceptibility to Salmonella typhimurium antigens 4 (Ssta4, Published QTL Chr 11)
|
|
GS207679: GO:0017085 response to insecticide
|
|
GS192509: GO:0006810 transport
|
|
GS187193: GO:0044057 regulation of system process
|
|
GS206395: GO:0051260 protein homooligomerization
|
|
GS206909: GO:0006952 defense response
|
|
GS190776: GO:0017085 response to insecticide
|
|
GS184978: GO:0032555 purine ribonucleotide binding
|
|
GS189202: GO:0010952 positive regulation of peptidase activity
|
|
GS128585: Rotarod Baseline Chr# 11
|
|
GS199112: GO:0044085 cellular component biogenesis
|
|
GS194065: GO:0016192 vesicle-mediated transport
|
|
GS197008: GO:0005887 integral to plasma membrane
|
|
GS84251: chronic alcohol withdrawal severity (Published QTL, Chr 11)
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS201838: GO:0044462 external encapsulating structure part
|
|
GS190714: GO:0016020 membrane
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS209450: GO:0006812 cation transport
|
|
GS182981: GO:0043067 regulation of programmed cell death
|
|
GS185961: GO:0051049 regulation of transport
|
|
GS188322: GO:0005524 ATP binding
|
|
GS135349: Alzheimer's disease modifier 1 (Azdm1, Published QTL Chr 11)
|
|
GS191552: GO:0042995 cell projection
|
|
GS195214: GO:0009987 cellular process
|
|
GS195112: GO:0071840 cellular component organization or biogenesis
|
|
GS208087: GO:0030313 cell envelope
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS193639: GO:0051641 cellular localization
|
|
GS180155: GO:0065009 regulation of molecular function
|
|
GS201794: GO:0032555 purine ribonucleotide binding
|
|
GS184920: GO:0007599 hemostasis
|
|
GS196168: GO:0005215 transporter activity
|
|
GS201997: GO:0005262 calcium channel activity
|
|
GS207733: GO:0052548 regulation of endopeptidase activity
|
|
GS206657: GO:0043933 macromolecular complex subunit organization
|
|
GS180817: GO:0022857 transmembrane transporter activity
|
|
GS201025: GO:0071702 organic substance transport
|
|
GS135461: bone mineral density 7 (Bomd7, Published QTL Chr 11)
|
|
GS168174: MP:0001919 abnormal reproductive system physiology
|
|
GS206417: GO:0002442 serotonin secretion involved in inflammatory response
|
|
GS201741: GO:0001508 regulation of action potential
|
|
GS187023: GO:1901265 nucleoside phosphate binding
|
|
GS36473: Cerebellum Gene expression correlates of Morphine - Severity of ptosis in Females BXD
|
|
GS198322: GO:0046873 metal ion transmembrane transporter activity
|
|
GS180664: GO:0002554 serotonin secretion by platelet
|
|
GS198263: GO:0005488 binding
|
|
GS206355: GO:0023052 signaling
|
|
GS135765: experimental allergic encephalomyelitis susceptibility 6b (Eae6b, Published QTL Chr 11)
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS201310: GO:0006873 cellular ion homeostasis
|
|
GS186798: GO:0030554 adenyl nucleotide binding
|
|
GS188308: GO:0010243 response to organic nitrogen
|
|
GS195977: GO:0007154 cell communication
|
|
GS177508: GO:0046467 membrane lipid biosynthetic process
|
|
GS189840: GO:0035150 regulation of tube size
|
|
GS136508: prion incubation determinant 3 (Pid3, Published QTL Chr 11)
|
|
GS205557: GO:0003012 muscle system process
|
|
GS135939: HDL level 39 (Hdl39, Published QTL Chr 11)
|
|
GS194905: GO:0008219 cell death
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS168923: MP:0002673 abnormal sperm number
|
|
GS204735: GO:0045121 membrane raft
|
|
GS198214: GO:0022892 substrate-specific transporter activity
|
|
GS182469: GO:0043234 protein complex
|
|
GS195194: GO:0015837 amine transport
|
|
GS207577: GO:0007270 neuron-neuron synaptic transmission
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS163842: MP:0000230 abnormal systemic arterial blood pressure
|
|
GS190124: GO:0042592 homeostatic process
|
|
GS135399: body growth early QTL 9 (Bgeq9, Published QTL Chr 11)
|
|
GS200275: GO:0014070 response to organic cyclic compound
|
|
GS178975: GO:0022607 cellular component assembly
|
|
GS180164: GO:0008150 biological_process
|
|
GS186658: GO:0030148 sphingolipid biosynthetic process
|
|
GS177667: GO:0006665 sphingolipid metabolic process
|
|
GS202897: GO:0050878 regulation of body fluid levels
|
|
GS205972: GO:0008015 blood circulation
|
|
GS205179: GO:0005524 ATP binding
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS207293: GO:0032879 regulation of localization
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS186108: GO:0006936 muscle contraction
|
|
GS186133: GO:0007320 insemination
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS185921: GO:0004871 signal transducer activity
|
|
GS182792: GO:0042060 wound healing
|
|
GS187769: GO:1901564 organonitrogen compound metabolic process
|
|
GS189666: GO:2000116 regulation of cysteine-type endopeptidase activity
|
|
GS203857: GO:0051291 protein heterooligomerization
|
|
GS185773: GO:0006643 membrane lipid metabolic process
|
|
GS209611: GO:0055082 cellular chemical homeostasis
|
|
GS177721: GO:0051234 establishment of localization
|